$AWHL Cashflow Statement | Understand Stock

$AWHL

$0.30 +$0.00 (0.0%) Close

$AWHL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash lease expense
Depreciation and amortization
Stock-based compensation expense
Change in fair value of warrant liabilities
Other expenses representing transaction costs allocated to the issuance of warrants
Change in fair value of March 2025 Convertible Notes
Loss upon issuance of March 2025 Convertible Notes carried at fair value
Loss on impairment and disposal of property and equipment
Forgiveness of PPP loan
Forgiveness of DECD loan
Financing expense for entering into equity line of credit with Lincoln Park
Financing expense for entering into 2025 Lincoln Park Equity Line of Credit

Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Inventories
Accounts payable, accrued liabilities and other liabilities
Accounts payable
Accrued liabilities
Other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of intangible assets
Net cash used in investing activities
Cash flows from financing activities:
Principal repayment of DECD loan
Proceeds from issuance of common stock from exercise of stock options
Payment of offering costs for public offering
Proceeds from equity line of credit
Proceeds from registered direct offering
Payment of issuance costs for registered direct offering
Proceeds from public offering
Payment of issuance costs for public offering
Proceeds from issuance of common stock from exercise of warrants
Proceeds from March 2025 Convertible Notes
Net cash provided by financing activities

Net decrease in cash and cash equivalents
Cash and cash equivalents , beginning of year
Cash and cash equivalents , end of year
Cash and cash equivalents
Restricted cash
Supplemental disclosure of cash flow information:
Cash paid for interest
Supplemental disclosure of noncash investing and financing activities:
Net increase in right-of-use assets
Forgiveness of PPP loan
Fair value of warrants issued in conjunction with common stock offering
Forgiveness of DECD loan
Warrants modification - incremental value
Commitment shares for equity line of credit
Increase in right-of-use assets
Fair value of warrants issued in conjunction with Warrant Inducement Agreement
Fair value of warrants issued upon conversion of Convertible Notes
Fair value of common stock issued upon conversion of Convertible Notes

Comments